This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lu, B. Articles by Hallahan, D. E. Search for Related Content PubMed PubMed Citation Articles by Lu, B. Articles by Hallahan, D. E.

Survivin As a Therapeutic Target for Radiation Sensitization in Lung Cancer

Departments of ¹ Radiation Oncology, and ² Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee; ³ Norris Comprehensive Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, California; and ⁴ Abbott Laboratories, Abbott Park, Illinois

Expression of survivin is elevated in most malignancies, especially in radiation-resistant cell lines. In this study, we investigated how radiation affects survivin expression in primary endothelial cells as well as in malignant cell lines. We found that 3 Gy significantly reduced survivin protein level in human umbilical vein endothelial cells (HUVECs) but not in tumor cell lines. Flow cytometry studies suggest that the down-regulation of survivin is independent of cell cycle. In addition, survivin mRNA level was also down-regulatable by irradiation. However, it was abrogated by actinomycin D-mediated inhibition of gene transcription. Luciferase reporter gene assays suggest that irradiation suppressed the survivin promoter. p53 overexpression reduced survivin expression, but overexpression of a p53 mutant failed to abolish the radiation-induced down-regulation in HUVECs. Alteration of p53 status in Val138 lung cancer cell line also failed to restore the radiation-inducible down-regulation. Overexpression of survivin in 293 cells prevented apoptosis induced by irradiation and increased cell viability after irradiation. The inhibition of survivin using antisense oligonucleotides caused a significant decrease in cell viability of irradiated H460 lung cancer cells. These data suggest that radiation transcriptionally down-regulates survivin in HUVECs. This regulatory mechanism is defective in malignancies and is not mediated by p53. Survivin overexpression may lead to resistance to radiotherapy by inhibiting apoptosis and enhancing cell viability. The inhibition of survivin results in sensitization of H460 lung cancer cells to radiation. These studies suggest that survivin may be a target for cancer therapy.

This article has been cited by other articles:

				J. Wang, Y. Jin, Z. Xu, Z. Zheng, and S. Wan Involvement of Caspase-3 Activity and Survivin Downregulation in Cinobufocini-Induced Apoptosis in A 549 Cells Experimental Biology and Medicine, May 1, 2009; 234(5): 566 - 572. [Abstract] [Full Text] [PDF]

				T. Iwasa, I. Okamoto, M. Suzuki, T. Nakahara, K. Yamanaka, E. Hatashita, Y. Yamada, M. Fukuoka, K. Ono, and K. Nakagawa Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines Clin. Cancer Res., October 15, 2008; 14(20): 6496 - 6504. [Abstract] [Full Text] [PDF]

				S. H. Oh, Q. Jin, E. S. Kim, F. R. Khuri, and H.-Y. Lee Insulin-like Growth Factor-I Receptor Signaling Pathway Induces Resistance to the Apoptotic Activities of SCH66336 (Lonafarnib) through Akt/Mammalian Target of Rapamycin-Mediated Increases in Survivin Expression Clin. Cancer Res., March 1, 2008; 14(5): 1581 - 1589. [Abstract] [Full Text] [PDF]

				S.-K. Seo, H.-O. Jin, H.-C. Lee, S.-H. Woo, E.-S. Kim, D.-H. Yoo, S.-J. Lee, S. An, C.-H. Rhee, S.-I. Hong, et al. Combined Effects of Sulindac and Suberoylanilide Hydroxamic Acid on Apoptosis Induction in Human Lung Cancer Cells Mol. Pharmacol., March 1, 2008; 73(3): 1005 - 1012. [Abstract] [Full Text] [PDF]

				R. P. Singh, A. Tyagi, G. Sharma, S. Mohan, and R. Agarwal Oral Silibinin Inhibits In vivo Human Bladder Tumor Xenograft Growth Involving Down-Regulation of Survivin Clin. Cancer Res., January 1, 2008; 14(1): 300 - 308. [Abstract] [Full Text] [PDF]

				R. Colnaghi, C. M. Connell, R. M. A. Barrett, and S. P. Wheatley Separating the Anti-apoptotic and Mitotic Roles of Survivin J. Biol. Chem., November 3, 2006; 281(44): 33450 - 33456. [Abstract] [Full Text] [PDF]

				K. W. Kim, R. W. Mutter, C. Cao, J. M. Albert, E. T. Shinohara, K. R. Sekhar, and B. Lu Inhibition of signal transducer and activator of transcription 3 activity results in down-regulation of Survivin following irradiation. Mol. Cancer Ther., November 1, 2006; 5(11): 2659 - 2665. [Abstract] [Full Text] [PDF]

				N. Wajapeyee, R. Britto, H. M. Ravishankar, and K. Somasundaram Apoptosis Induction by Activator Protein 2{alpha} Involves Transcriptional Repression of Bcl-2 J. Biol. Chem., June 16, 2006; 281(24): 16207 - 16219. [Abstract] [Full Text] [PDF]

				Y. Li, Y.-H. Song, J. Mohler, and P. Delafontaine ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2116 - H2123. [Abstract] [Full Text] [PDF]

				J.-I Chao and H.-F. Liu The Blockage of Survivin and Securin Expression Increases the Cytochalasin B-Induced Cell Death and Growth Inhibition in Human Cancer Cells Mol. Pharmacol., January 1, 2006; 69(1): 154 - 164. [Abstract] [Full Text] [PDF]

				S. Giagkousiklidis, M. Vogler, M.-A. Westhoff, H. Kasperczyk, K.-M. Debatin, and S. Fulda Sensitization for {gamma}-Irradiation-Induced Apoptosis by Second Mitochondria-Derived Activator of Caspase Cancer Res., November 15, 2005; 65(22): 10502 - 10513. [Abstract] [Full Text] [PDF]

				H. Dote, D. Cerna, W. E. Burgan, K. Camphausen, and P. J. Tofilon ErbB3 Expression Predicts Tumor Cell Radiosensitization Induced by Hsp90 Inhibition Cancer Res., August 1, 2005; 65(15): 6967 - 6975. [Abstract] [Full Text] [PDF]

				F. Rodel, J. Hoffmann, L. Distel, M. Herrmann, T. Noisternig, T. Papadopoulos, R. Sauer, and C. Rodel Survivin as a Radioresistance Factor, and Prognostic and Therapeutic Target for Radiotherapy in Rectal Cancer Cancer Res., June 1, 2005; 65(11): 4881 - 4887. [Abstract] [Full Text] [PDF]